Zepbound is described as a dual agonist because it activates both the GIP and GLP-1 receptors simultaneously
Glucagon-like peptide-1 (GLP-1) receptor agonists mimic (copy) the GLP-1 hormone that is naturally released in your gastrointestinal (GI) tract in response to food
As the latest weight loss miracle drug, tirzepatide combines the dual hormonal functions of GLP-1 and GIP, which not only effectively controls appetite, but also significantly improves blood sugar levels
doi: 10.3389/fonc.2023.990551
2 Materials and methods 2.1 Scope Samples declared as containing substances intended to enhance sports performance, such as AAS, other PEDs, or substances used after the AAS cycle to mitigate side effects, were included
Thursday was the final cut-off for compounded semaglutide